Metropolitan Life Insurance CO Vaxart, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2023	BUY	$0.75 - $2.24 $6,045 - $18,054	8,060 New	8,060 $7.75 Million
Q4 2022 Mar 30, 2023	BUY	$0.75 - $2.24 $401 - $1,198	535 Added 7.11%	8,060 $7,000
Q4 2022 Feb 15, 2023	BUY	$0.75 - $2.24 $401 - $1,198	535 Added 7.11%	8,060 $7,000
Q3 2022 Jun 14, 2023	BUY	$2.09 - $4.5 $15,727 - $33,862	7,525 New	7,525 $16.4 Million
Q3 2022 Mar 30, 2023	BUY	$2.09 - $4.5 $4,819 - $10,377	2,306 Added 44.18%	7,525 $16,000
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $4,819 - $10,377	2,306 Added 44.18%	7,525 $16,000
Q2 2022 Jun 20, 2023	BUY	$2.7 - $5.28 $14,091 - $27,556	5,219 New	5,219 $18,000
Q2 2022 Mar 30, 2023	SELL	$2.7 - $5.28 $8,086 - $15,813	-2,995 Reduced 36.46%	5,219 $18,000
Q2 2022 Aug 11, 2022	SELL	$2.7 - $5.28 $8,086 - $15,813	-2,995 Reduced 36.46%	5,219 $18,000
Q1 2022 Jun 20, 2023	BUY	$4.29 - $6.64 $35,238 - $54,540	8,214 New	8,214 $41,000
Q1 2022 Mar 30, 2023	SELL	$4.29 - $6.64 $75,521 - $116,890	-17,604 Reduced 68.18%	8,214 $41,000
Q1 2022 May 12, 2022	SELL	$4.29 - $6.64 $75,521 - $116,890	-17,604 Reduced 68.18%	8,214 $41,000
Q4 2021 Jun 21, 2023	BUY	$5.77 - $7.96 $148,969 - $205,511	25,818 New	25,818 $161,000
Q4 2021 Mar 30, 2023	SELL	$5.77 - $7.96 $5,060 - $6,980	-877 Reduced 3.29%	25,818 $161,000
Q4 2021 Feb 15, 2022	SELL	$5.77 - $7.96 $5,060 - $6,980	-877 Reduced 3.29%	25,818 $162,000
Q3 2021 Jun 21, 2023	BUY	$6.67 - $9.8 $178,055 - $261,611	26,695 New	26,695 $212,000
Q3 2021 Mar 30, 2023	SELL	$6.67 - $9.8 $50,411 - $74,068	-7,558 Reduced 22.07%	26,695 $212,000
Q3 2021 Nov 15, 2021	SELL	$6.67 - $9.8 $50,411 - $74,068	-7,558 Reduced 22.07%	26,695 $212,000
Q2 2021 Jun 21, 2023	BUY	$5.06 - $10.78 $173,320 - $369,247	34,253 New	34,253 $256,000
Q2 2021 Mar 30, 2023	BUY	$5.06 - $10.78 $101,240 - $215,686	20,008 Added 140.46%	34,253 $256,000
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $173,249 - $369,096	34,239 Added 244564.3%	34,253 $257,000
Q1 2021 Jun 26, 2023	BUY	$5.64 - $23.33 $80,341 - $332,335	14,245 New	14,245 $86.2 Million
Q1 2021 Mar 30, 2023	SELL	$5.64 - $23.33 $14,021 - $57,998	-2,486 Reduced 14.86%	14,245 $86,000
Q1 2021 May 14, 2021	SELL	$5.64 - $23.33 $94,283 - $390,007	-16,717 Reduced 99.92%	14 $86,000
Q4 2020 Jun 22, 2023	BUY	$3.5 - $7.98 $58,558 - $133,513	16,731 New	16,731 $95,000
Q4 2020 Mar 30, 2023	BUY	$3.5 - $7.98 $3,930 - $8,961	1,123 Added 7.2%	16,731 $95,000
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $3,930 - $8,961	1,123 Added 7.2%	16,731 $96,000
Q3 2020 Jun 26, 2023	BUY	$4.78 - $16.97 $74,606 - $264,867	15,608 New	15,608 $103,000
Q3 2020 Mar 30, 2023	BUY	$4.78 - $16.97 $1,061 - $3,767	222 Added 1.44%	15,608 $103,000
Q3 2020 Nov 13, 2020	BUY	$4.78 - $16.97 $1,061 - $3,767	222 Added 1.44%	15,608 $104,000
Q2 2020 Jun 26, 2023	BUY	$1.68 - $8.85 $25,848 - $136,166	15,386 New	15,386 $136,000
Q2 2020 Mar 30, 2023	BUY	$1.68 - $8.85 $12,307 - $64,835	7,326 Added 90.89%	15,386 $136,000
Q2 2020 Aug 14, 2020	BUY	$1.68 - $8.85 $25,848 - $136,166	15,386 New	15,386 $136,000

Others Institutions Holding VXRT

# of Institutions

107

Shares Held

37.7M

Call Options Held

188K

Put Options Held

180K

Sio Capital Management, LLC New York, NY

13.6M
Shares

$9.25 Million
6.11% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$6.85 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.97M
Shares

$2.7 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

2.54M
Shares

$1.73 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.77M
Shares

$1.21 Million
0.0% of portfolio

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account